CUAMC
EDIT icon

China Universal Asset Management Company’s Editas Medicine EDIT Stock Holding History

China Universal Asset Management Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8K Buy
17,323
+1,416
+9% +$3K ﹤0.01% 466
2025
Q4 		$32.6K Buy
15,907
+145
+0.9% +$419 ﹤0.01% 475
2025
Q3 		$54.7K Sell
15,762
-1,051
-6% -$2.93K ﹤0.01% 425
2025
Q2 		$37K Buy
16,813
+255
+2% +$417 ﹤0.01% 436
2025
Q1 		$19.2K Sell
16,558
-945
-5% -$1.39K ﹤0.01% 457
2024
Q4 		$22.2K Buy
17,503
+1,640
+10% +$4.18K ﹤0.01% 482
2024
Q3 		$54.1K Buy
15,863
+6,202
+64% +$27K 0.01% 383
2024
Q2 		$45.1K Sell
9,661
-6,052
-39% -$34.1K 0.01% 365
2024
Q1 		$117K Buy
15,713
+6,263
+66% +$52K 0.01% 357
2023
Q4 		$95.7K Buy
9,450
+7,355
+351% +$64.6K 0.02% 285
2023
Q3 		$16.3K Buy
2,095
+1,190
+131% +$10.2K ﹤0.01% 312
2023
Q2 		$7.45K Sell
905
-30
-3% -$261 ﹤0.01% 337
2023
Q1 		$6.78K Buy
935
+237
+34% +$2.11K ﹤0.01% 339
2022
Q4 		$6.19K Buy
698
+54
+8% +$593 ﹤0.01% 272
2022
Q3 		$8K Buy
+644
New +$10K ﹤0.01% 223

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

China Universal Asset Management Company's EDIT Position: Q1 2026 in Review

China Universal Asset Management Company increased its Editas Medicine (EDIT) stake by 8.9% in Q1 2026, buying an estimated $3K and bringing the position to 17,323 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

China Universal Asset Management Company first reported a position in EDIT in Q3 2022 and has held it in 15 quarters since. The position peaked at $117K in Q1 2024. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • China Universal Asset Management Company held 17,323 shares of Editas Medicine worth $42.8K as of Q1 2026.
  • China Universal Asset Management Company bought 1,416 Editas Medicine shares in Q1 2026, an estimated $3K.
  • Editas Medicine made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #466 holding.
  • China Universal Asset Management Company first reported a position in Editas Medicine in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Editas Medicine position peaked at $117K in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.